Frequently Asked Questions
The market is segmented based on , By Type (TSH Test, T4 Test, T3 Test, Others), End User (Hospitals and Clinics, Diagnostic Laboratory, Research Laboratories and Institutes, Others) – Industry Trends and Forecast to 2030.
.
The Global Thyroid Function Test Market size was valued at USD 1.79 USD Billion in 2022.
The Global Thyroid Function Test Market is projected to grow at a CAGR of 6.7% during the forecast period of 2023 to 2030.
The major players operating in the market include , Teva Pharmaceutical Industries Ltd , Mylan N.V , Johnsons & Johnsons Services , F. Hoffman,La Roche , Lilly , Merck & Co. , Aurobindo Pharma , Bristol,Myers Squibb Company , GSK plc , Ascendis Pharma A/S , Sanofi , Pfizer , BIOMÉRIEUX , Abbott , QIAGEN , Thermo Fisher Scientific , Siemens , Danaher , DiaSorin S.p.A , Quidel Corporation , Meridian Bioscience , MedLife , Randox Laboratories Ltd .
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
